Adherex Technologies Incorporated
Adherex Technologies is a biotechnology company developing novel therapeutics based on cell adhesion technologies. Adherex is currently developing a portfolio of biologically active small molecules...
www.adherex.com/ View full profile
| |
Angiogenesis Technologies Incorporated
...
www.angiogene.com/ View full profile
| |
Collateral Therapeutics Incorporated
Collateral's initial non-surgical gene therapy products under investigation are designed to promote and enhance angiogenesis, a natural biological process which results in the growth of additional...
www.collateralthx.com/ View full profile
| |
CardioGenesis Corporation
Global leader in TMR and PMR (International markets only)
An innovative and leading angiogenesis device company providing products that stimulate cardiac angiogenesis
...
www.eclipsesurg.com/ View full profile
| |
CardioVascular BioTherapeutics
CardioVascular BioTherapeutics, Inc. (OTC/BB: CVBT) is a biopharmaceutical company focused on developing protein drug candidates to be used in the treatment of cardiovascular disease, the worldwide...
www.cvbt.com/ View full profile
| |
EntreMed Incorporated
EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the blood vessels that nourish them. EntreMed is...
www.entremed.com/ View full profile
| |
Genaera
Genaera Corporation is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. Our research and development efforts are focused on anti...
www.genaera.com/ View full profile
| |
ILEX Oncology
Based in San Antonio, Texas, ILEX has a marketed product, Campath®, a treatment for patients with refractory chronic lymphocytic leukemia. ILEX is also advancing a robust pipeline of oncology product...
www.ilexonc.com/ View full profile
| |
Oncogene Research Products
Assays, ELISAs, antibodies, growth factors, receptors, ligands peptides, probes, hormones, neurotoxins, and enzymes for the study of angiogenesis, apoptosis, cancer, cell cycle/proliferation,...
www.oncresprod.com/ View full profile
| |
Lorus Therapeutics
Lorus Therapeutics Inc. is a pharmaceutical company focused on the development of cancer therapies. Lorus' goal is to capitalize on its pre-clinical, clinical and regulatory expertise by developing...
www.lorusthera.com/ View full profile
| |
Paragon Bioservices Incorporated
Paragon Bioservices apply focused capabilities to client needs throughout each stage of discovery and preclinical development. Current areas of active involvement include:Aging, Angiogenesis,...
www.bioserv-diagnostics.com/ View full profile
| |
Renovis
Renovis is a science-driven, biopharmaceutical company that seeks to discover, develop and commercialize therapeutics for major medical needs in the areas of neurological and inflammatory diseases....
www.renovis.com/ View full profile
| |
Trevigen Incorporated
Trevigen is a long standing provider of quality kits and reagents for researchers investigating programmed cell death, DNA damage and repair, cell differentiation and angiogenesis. Trevigen recently...
www.trevigen.com/ View full profile
| |
AngioGenetics AB
AngioGenetics is a Swedish biotechnology company focusing on discovery, development, and commercialisation of novel angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease,...
www.angiogenetics.se/ View full profile
| |
Arteriocyte, Inc.
Arteriocyte’s focus is the development of stem cell-based therapies to treat ischemia in patients suffering from coronary artery disease, peripheral vascular disease, stroke, and renal ischemia. The...
www.arteriocyte.com/ View full profile
| |
